These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7039824)

  • 1. Treatment of multiple myeloma.
    Woodruff R
    Cancer Treat Rev; 1981 Dec; 8(4):225-70. PubMed ID: 7039824
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple myeloma.
    Parker D; Malpas JS
    J R Coll Physicians Lond; 1979 Jul; 13(3):146-53. PubMed ID: 381645
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma cell myeloma. An interpretive review.
    Bergsagel DE
    Cancer; 1972 Dec; 30(6):1588-94. PubMed ID: 4565818
    [No Abstract]   [Full Text] [Related]  

  • 4. The chemotherapy of plasma cell myeloma and related disorders.
    Coleman M; Silver RT
    Antibiot Chemother (1971); 1974; 18():112-47. PubMed ID: 4219116
    [No Abstract]   [Full Text] [Related]  

  • 5. [Results of plasmacytoma therapy of ALGB (acute leukemia group B)].
    Obrecht JP
    Hamatol Bluttransfus; 1976; 18():383-93. PubMed ID: 964714
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple myeloma: a therapeutic enigma.
    Hoogstraten B
    Am J Clin Oncol; 1982 Feb; 5(1):13-9. PubMed ID: 7081135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined cytostatic therapy of plasmacytoma].
    Albert P; Zsuzsa M
    Orv Hetil; 1977 Jul; 118(31):1855-6. PubMed ID: 887257
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of multiple myeloma.
    Kyle RA; Maldonado JE; Bayrd ED
    Mayo Clin Proc; 1968 Oct; 43(10):730-7. PubMed ID: 5711940
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy of multiple myeloma. Review of the recent trials].
    Tribalto M; Arcese W; Colombo R; Pastore S; Franchii A
    Recenti Prog Med; 1981 Aug; 71(2):141-7. PubMed ID: 7031807
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recent progress in chemotherapy of multiple myeloma].
    Tortarolo M; Cantore N; Russolillo S; Castaldo C; Buonanno G
    Recenti Prog Med; 1978 Jul; 65(1):44-68. PubMed ID: 370935
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple myeloma terminating in acute leukemia. Report of 12 cases and review of the literature.
    Rosner F; Grünwald H
    Am J Med; 1974 Dec; 57(6):927-39. PubMed ID: 4611209
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemotherapy of multiple bone myeloma. Historical and present day aspects. (Second part) (author's transl)].
    Bataille R; Morlock G; Rosenberg F; Sany J; Serre H
    Sem Hop; 1979 Sep 18-25; 55(31-32):1377-82. PubMed ID: 228415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutiple myeloma resistant to melphalan (NSC-8806) treated with cyclophosphamide (NSC-26271), prednisone (NSC-10023), and chloroquine (NSC-187208).
    Kyle RA; Seligman BR; Wallace HJ; Silver RT; Glidewell O; Holland JF
    Cancer Chemother Rep; 1975; 59(3):557-62. PubMed ID: 1203882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol.
    Case DC; Lee DJ; Clarkson BD
    Am J Med; 1977 Dec; 63(6):897-903. PubMed ID: 605911
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of myeloma].
    Le Chevallier PL
    Sem Hop; 1971 Jan; 47(4):249-51. PubMed ID: 4322132
    [No Abstract]   [Full Text] [Related]  

  • 16. [Survival and therapy of multiple myeloma. Apropos of 56 observed cases].
    Locatelli F; Giovanelli E; Neretto G; Furno F; Pellerito R
    Minerva Med; 1979 Mar; 70(13):925-33. PubMed ID: 220567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudohypercalcemia and hyperviscosity with neurological manifestations in multiple myeloma.
    van Dijk JM; Sonnenblick M; Weissberg N; Rosin A
    Isr J Med Sci; 1986 Feb; 22(2):143-4. PubMed ID: 3753959
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood and neoplastic diseases. Myelomatosis.
    Malpas JS
    Br Med J; 1974 Nov; 4(5943):520-2. PubMed ID: 4434121
    [No Abstract]   [Full Text] [Related]  

  • 19. Adriamycin, 1,3-bis (2-chloroethyl) 1 nitrosourea (BCNU, NSC No. 409962), cyclophosphamide plus prednisone (ABC-P) in melphalanresistant multiple myeloma.
    Presant CA; Klahr C
    Cancer; 1978 Sep; 42(3):1222-7. PubMed ID: 698913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current concepts in cancer. Multiple myeloma.
    McIntyre OR
    N Engl J Med; 1979 Jul; 301(4):193-6. PubMed ID: 377077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.